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Summary.-Tumour-associated prostaglandin-like material, assessed by bioassay,
has been examined in 37 patients with primary and metastatic squamous carcinomas
of the head and neck, previously treated by radiotherapy and chemotherapy followed
by radical surgery. High amounts of prostaglandin-like material were extracted
from tumours excised within 3 months of radiotherapy and chemotherapy. These
amounts correlated with necrosis, inflammation and fibrosis, but not with tumour
site, size or degree of differentiation. Most of the prostaglandins formed by these
treated tumours thus seem to be associated with host stromal and inflammatory
cells, rather than the neoplastic cells. The possible roles of prostaglandins in
facilitating the spread of squamous carcinomas are discussed.
THE AMOUNTS OF PROSTAGLANDINS ex-
tracted from various tumours, notably
from human carcinomas of the breast
(Bennett et al., 1975, 1976; Powles et al.,
1976), large intestine (Bennett et al., 1977)
and kidney (Atkins et al., 1977) and from
certain experimental neoplasms (Powles
et al., 1973; Tashjian et al., 1974; Galasko,
1.976; Galasko & Bennett, 1976) are usually
greater than from the corresponding nor-
mal tissues. Prostaglandins and other less-
clearly defined "tumour-associated" pro-
ducts may be involved in the establish-
ment and growth of metastases in bone
and possibly in other sites (Carter, 1978;
Bennett, 1979). Prostaglandin E2 (PGE2)
and some other prostanoids stimulate
osteoclasts (Galasko, 1976; Carter, 1978;
Bennett, 1979) and the recent observation
of pronounced osteoclastic activity asso-
ciated with squamous carcinomas of the
head and neck invading bone (Carter &
Tanner, 1979; Carter etal., 1980) prompted
the present investigation.
PATIENTS AND METHODS
Studies were made on 37 patients from the
Royal Marsden and King's College Hospitals
wN-ith histologically proven squamous car-
cinomas of the head and neck. There wNere
32 males and 5 females, aged between 27 and
70 years (median 59). Large (T3, T4) tumours
predominated. The sites of the primary
carcinomas were as follows: larynx 11, tongue
10, oral cavity (lip, floor of mouth, alveolus,
soft palate, buccal mucosa) 8, oropharynx 5,
nose and paranasal sinuses 2, hypopharynx
1, and external auditory meatus 1. One
patient had two primary carcinomas (oro-
pharynx and oral cavity). All patients had
been previously treated, either by radio-
therapy (10) or by combined radiotherapy
and chemotherapy (27), 1 to 80 months
(median 3 months) before radical surgery.
The radiotherapy given was from a Cobalt-60
unit at fractions of 200 rad over about 6
weeks, to a final dose of between 4,000 and
8,000 rad (median 6,000 rad). Chemotherapy,
given either before or synchronized with
radiotherapy, consisted of combinations of
vincristine, bleomycin, methotrexate and
5-fluorouracil (O'Connor et al., 1977; Price
& Hill, 1977).
Prostaglandin-like material was extracted
from residual or locally recurrent primary
carcinomas and from cervical lymphnode
metastases. Irradiated but macroscopically
normal mucosa from a distant resection line,
and uninvolved lymph nodes, served as con-PROSTAGLANDINS IN SQUAMOUS CARCINOMA
trol tissues. In 14 patients blood from the
antecubital vein and the internal jugular vein
was sampled at the time of surgery, for
prostaglandin assay. Swabs for routine
bacteriological culture were taken from all
excised tumours. A part of each specimen
taken for prostaglandin assay, and the re-
mainder of the surgical specimen, were
examined by standard histopathological pro-
cedures.
Tissues for assay were collected in dry,
sterile containers and sent to the laboratory
within 1 h of removal. They were then cut
into small pieces with scissors and washed
with Krebs' solution. Weighed samples were
homogenized either in Krebs' solution to
estimate prostaglandin-synthesizing ability,
or in acidified aqueous ethanol to determine
"basal" prostaglandins (Bennett et al., 1973).
Amounts synthesized from endogenous pros-
taglandin precursors released during homo-
genization were estimated by subtracting
"basal" amounts from the "total" extracted
from the homogenate in Krebs' solution
(Unger et al., 1971). The extracted material
was assayed against PGE2, using the rat
gastric fundus strip preparation treated with
various antagonists which increase the selec-
tivity and sensitivity of the assay (Bennett
et al., 1973). Tentative characterization ofthe
prostaglandin-like material extracted from
14 tumour homogenates was made by chro-
matography, using paper impregnated with
silica gel, and the solvent system for group
separation of PGE and PGF compounds
(Stamford & Unger, 1972). Samples ofvenous
blood were collected in lithium heparin tubes
containing indomethacin (final concentration
10 ,tg/ml blood) and the prostaglandins
extracted from the plasma (Unger et al.,
1971). The assay results are expressed as ng
PGE2 equivalents/g fresh tissue (median and
semiquartile ranges) and analysed statis-
tically by the Mann-Whitney U test or by
Spearman's rank correlation.
RESULTS
Seventy assays of prostaglandin-like
material were made on 33 primary squa-
mous carcinomas, 9 lymphnode metas-
tases and 28 control specimens of un-
involved mucosa -and lymph nodes. All
the tissues had been previously irradiated,
and those which were infected (as shown
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FIG. 1. Amounts of "total" prostaglandin-
like material (ng PGE2 equivalent/g on the
vertical axis) extracted from residual or
recurrent primary squamous carcinomas
were significantly higher than from nodal
metastases or uninvolved mucosa and
lymph nodes.
by swab cultures) were excluded. The
amounts of "total" prostaglandin-like
activity extracted from homogenates in
Krebs's solution in these 3 groups are
summarized in Fig. 1, expressed as median
PGE2 equivalents/g fresh tissue with
semiquartile ranges in parentheses. The
amounts extractedfromprimarysquamous
carcinomas (108(40-195)ng PGE2 equiva-
lents/g) were significantly higher than
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1 metastases (18(6-35)ng; P= material of > 200ng PGE2 equivalents/g
from uninvolved mucosa and fresh tissue than did primary tumours
les (32(8-75)ng; P= 0.006). The removed after longer intervals (P=0 04).
rom nodal metastases and un- No association was detected between total
ymph nodes or mucosa wvere not prostaglandins and the tumour site, size
ly different (P = 0.4). or degree of differentiation. High amounts
site, size, degree of differentia- of prostaglandin-like activity (total
)sis, inflammation and fibrosis amounts 72(22-118)ng PGE2 equivalents/
nined by one of us (RLC) g) were extracted from many tumours
rior knowledge of the prosta- showing direct invasion of bone or ossified
esults. Tumour total prosta- laryngeal cartilage with marked osteo-
,orrelated with the extent of elastic activation, but these amounts were
nflammation and fibrosis, each not significantly different from tumours
an arbitrary 1-3 point system invading soft tissues. In a relatively short
). and they tended to correlate postoperative follow-up of 3-21 months,
total prostaglandin amounts from primary
e1700 e1950 or metastatic tumours did not correlate
05 04 with patient survival time.
High yields of prostaglandin-like mate-
rial were also associated with local necrosis,
inflammation and fibrosis in some control
tissues. Two uninvolved lymph nodes with
* the high amounts of 420 and 460 ng PGE2
* equivalents/g showed intense reactive
*o hyperplasia with sinus histiocytosis; both
nodes were enlarged and had been thought
clinically to contain metastatic carcinoma.
0 * Two specimens ofmacroscopically normal
0 * | mucosa yielding 150 and 200 ng PGE2
equivalents/g were inflamed, and one
* 0 * showed marked epithelial dysplasia.
0 ° | Sufficient material was available to ole's o nmeasure "basal" amounts of prostaglan-
@ 0 | o dins, and therefore "synthesized" amounts
7 5 7 9 (total-basal) in 12 primary tumours, 5
nodal metastases and 4 specimens of
uninvolved mucosa. "Total" amounts of MORPHOLOGICAL SCORE. tumour prostaglandins were high when
imounts of "total" prostaglan(lin- "synthesized" amounts were high, and
,erial (ng PGE2 equivalent/g on the vice versa P < 0 00I but there axis) extracted from residlual or (correlation primary squamouis carcinomas were insufficient data to assess the rela-
id from no(lal metastases () tionship in uninvolved tissues. witlh morphological scores of
inflammation an(l fibrosis (arbi- Chromatography of the "total prosta- its 1-9;.see text). glandin" in homogenates of 14 recurrent
carcinomas indicated the presence of
with the interval between ex- several prostaglandinsin varying amounts,
radiotherapy with or without running with PGE1, PGE2, PGE3, PGF1a,
apy (P = 0 06). More primary PGF2, and PGF3j. PGE2-like material
removed within 3 months of was present in all the extracts, with
,py with or without cherno amounts ranging from 1500 to 98%
ielded total prostaglan(lin-like (median (iOo0) of the total biological
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activity assessed by the rat fundus-strip
assay.
There was no consistent difference
between the amounts of prostaglandins
extracted from the peripheral venous
blood (antecubital vein) of 12 patients
and the blood draining the tumour-bearing
area (internal jugular vein).
1)ISCUSSION
The methods used here do not permit
exact identification and quantitation of
the individual prostaglandins. Indeed,
there is no technique available which can
do this with all the lipid derivatives in the
small amounts of tumour available for
study. Our bioassay measures the ability
of relatively stable extracted lipids to
contract rat gastric fundus, but under-
estimates substances with low biological
activity on this tissue. Clearly the amounts
of assayed biological activity are higher in
extracts of treated primary squamous
carcinomas of the head and neck than of
nodal metastases or normal tissue. The
morphological findings indicate that these
high amounts of prostaglandins correlate
with necrosis, inflammation and fibrosis in
and around the primary tumour rather
than with more specific attributes of the
tumour itself, such as its site, size and
degree of differentiation. Necrosis, in-
flammation and related changes are likely
to be more pronounced after irradiation
and chemotherapy, and total amounts of
prostaglandins were often higher in tu-
mours removed within 3 months of such
treatment. Various forms of local damage,
including ionizing radiation (Eisen &
Walker, 1976) can increase the amounts of
prostaglandin in tissue.
Much of the prostaglandins extracted
from treated primary squamous car-
cinomas of the head and neck may reflect
the activity of host stromal and inflam-
matory cells particularly macrophages
(Myatt et al., 1975; Humes et al., 1977;
Carter, 1978; Bennett, 1979) rather than
the tumour cells themselves, though
squamous-carcinoma cells presumably
synthesize someprostaglandins. Thismight
explain the unexpected finding ofdifferent
total amounts ofprostaglandins in extracts
of primary squamous carcinomas and
cervical-node metastases. Necrosis and
subacute inflammation are frequently
marked in primary squamous carcinomas
of the head and neck, and such changes
are exacerbated during and immediately
after irradiation and chemotherapy. Meta-
static squamous carcinoma in lymph nodes
often becomes necrotic, but local inflam-
mation is uncommon unless a nodal mass
fungates and becomes secondarily infec-
ted; none of the tumours in this study
was overtly infected. The occasional high
amounts of prostaglandin-like material
extracted from uninvolved control tissues
(Fig. 1) were attributed either to subacute
inflammation or, in the case of the lymph
nodes, to marked sinus histiocytosis.
There was no evidence of prostaglandin
release from the tumours into the blood.
If prostaglandin E or F compounds had
been released, the levels ofPG-likematerial
in plasma from the internal jugular vein
would be higher than in peripheral venous
plasma since most of the prostaglandin E
or F compounds liberated from the tumour
would be inactivated in the pulmonary
circulation. On the other hand, any pros-
taglandin released from these treated
tumours would inevitably be diluted by
blood from other regions of the head
and neck, and may therefore have been
undetectable in our bioassay. Many
breast tumours release prostaglandin-like
material into the blood (Stamford et al.,
1979) and recalculation of data from a
previous report (Mortel et al., 1977) sug-
gest that prostaglandins are released from
some pelvic carcinomas (Bennett, 1979).
In addition, recent work from our depart-
ment (Tanner et al., unpublished) has
shown an association between increased
levels of prostaglandin-like material in
peripheral venous plasma and the degree
ofradiation-induced mucositis, a complica-
tion which severely limits effective radio-
therapy.
Since all the tumours examined here had
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been previously treated, it is not appro-
priate to compare the results with those
obtained with untreated human tumours
of other types. This may explain the ab-
sence of a correlation between tumour
prostaglandins and patient survival (cf.
Bennett et al., 1979) though the numbers
of patients here are small. Nevertheless,
prostaglandins associated with osteolytic
primary squamous carcinomas ofthe head
and neck may facilitate the direct spread
ofstrategically placed tumours to adjacent
bone or ossified cartilage (Carter et al.,
1980; Carter & Tanner, 1979).
Several studies in laboratory animals
have demonstrated benefits of using
prostaglandin synthesis inhibitors in the
treatment of malignant disease (Bennett,
1979), and a trial is now in progress at
King's College Hospital to evaluate flur-
biprofen in the clinical management of
patients with advanced (T3, T4) squamous
carcinomas of the head and neck who are
initially treated by radiotherapy (with or
without chemotherapy) before planned
radical surgery.
We are indebted to Mr Peter Clifford, F.R.C.S.,
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